Statistics for Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER Study
Total visits
views | |
---|---|
Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER Study | 159 |
Total visits per month
views | |
---|---|
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
May 2025 | 0 |
June 2025 | 0 |
File Visits
views | |
---|---|
Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease.pdf | 125 |
java.util.UUID:8fdc4e01-cc05-4fd4-afb6-f174e44fd852 | 33 |
java.util.UUID:034c9db3-8c86-4d49-8747-bd6da18cec71 | 12 |
java.util.UUID:6cdd9235-e92b-4d56-9026-e40dbb187a19 | 12 |
Top country views
views | |
---|---|
United States | 116 |
Sweden | 8 |
Germany | 6 |
United Kingdom | 5 |
Ukraine | 5 |
Canada | 2 |
China | 1 |
Malaysia | 1 |
Russia | 1 |
Top city views
views | |
---|---|
Wilmington | 47 |
Fairfield | 19 |
Cambridge | 9 |
Stockholm | 7 |
Houston | 6 |
Jacksonville | 6 |
White Plains | 6 |
Kiev | 5 |
Kiez | 5 |
San Francisco | 2 |
Toronto | 2 |
Ann Arbor | 1 |
Brooklyn | 1 |
Gunzenhausen | 1 |
Laurel | 1 |
Moscow | 1 |
Mount Laurel | 1 |
Scottsdale | 1 |
Seremban | 1 |
Älvsjö | 1 |